Company intelligence / Profile preview

Theoreo

Salerno, Campania, Italytheoreosrl.com ↗

Ownership: Private
Development stage: Other

Overview

Theoreo Srl is developing innovative, non-invasive diagnostic tests for early detection of fetal malformations and endometrial carcinoma using metabolomics and machine learning. Their technology aims to revolutionize prenatal and oncological care by enabling early diagnosis from a single blood sample. They have also developed the "MAMA Test" for early non-invasive diagnostics[2].

Therapeutic areas: GastroenterologyOncologyWomen's Health
Modalities: Diagnostic testMachine learning-based diagnostic
Industry: Metabolite Diagnostics

Partnerships

None publicly disclosed; spin-off from University of Salerno[2]

Beyond the preview

Go deeper on Theoreo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Theoreo.

Explore the full profile